Clinical and molecular detection of inherited colorectal cancers in northeast Italy A first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy

被引:4
作者
Urso, E. [1 ,2 ]
Agostini, M. [1 ,2 ,3 ,4 ]
Pucciarelli, S. [1 ,2 ]
Rugge, M. [5 ]
Bertorelle, R.
Maretto, I. [1 ,2 ]
Bedin, C. [1 ,2 ,4 ]
D'Angelo, E. [4 ]
Mescoli, C. [5 ]
Zorzi, M.
Viel, A.
Bruttocao, G.
Ferraro, B.
Erroi, F. [6 ]
Contin, P. [1 ,2 ]
De Salvo, G. L. [7 ]
Nitti, D. [1 ,2 ]
机构
[1] Univ Padua, Clin Chirurg 2, Dipartimento Sci Chirurg Oncol & Gastroenterol, Padua, Italy
[2] Policlin Padua, I-35128 Padua, Italy
[3] Methodist Hosp, Dept Nanomed, Res Inst, Houston, TX 77030 USA
[4] Ist Ric Pediat, Padua, Italy
[5] Univ Padua, Serv Anat Patol, Padua, Italy
[6] Univ Padua, Clin Chirurg 3, Padua, Italy
[7] IOV IRCCS, Serv Epidemiol Clin, Padua, Italy
关键词
Lynch syndrome; Incidence of familial CRCs; Genetics screening; INTERNATIONAL-COLLABORATIVE-GROUP; MICROSATELLITE-INSTABILITY; GERMLINE MUTATIONS; MYH GENE; HEREDITARY; CRITERIA; IMMUNOHISTOCHEMISTRY; FAMILIES; HNPCC; PREDISPOSITION;
D O I
10.1007/s13277-011-0312-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The reported incidence of hereditary colorectal cancers (CRCs) is widely variable. The principal aim of the study was to prospectively evaluate the incidence of familial CRCs in a region of northern Italy using a standardized method. Consecutive CRC patients were prospectively enrolled from October 2002 to December 2003. Patients underwent a structured family history, the microsatellite instability (MSI) test and a screen for MUTYH mutations. Following family history patients were classified as belonging to high, moderate and mild risk families. Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 proteins and investigation for MLH1/MSH2 mutations, for MLH1 promoter methylation and for the V600E hotspot BRAF mutation were performed in high MSI (MSI-H) cases. Of the 430 patients enrolled, 17 (4%) were high risk [4 hereditary non-polyposis colorectal cancer (HNPCC), 12 suspected HNPCC and 1 MUTYH-associated adenomatous polyposis coli (MAP)], 53 moderate risk and 360 mild risk cases. The MSI test was performed on 393 tumours, and 46 (12%) of them showed MSI-H. In these patients, one MLH1 pathogenetic mutations and two MSH2 pathogenetic mutations were found. Thirty-two (70%) MSI-H cases demonstrated MLH1 methylation and/or BRAF mutation: None of them showed MLH1/MSH2 mutation. Two biallelic germline MUTYH mutations were found, one with clinical features of MAP. A strong family history of CRC was present in 4% of the enrolled cases; incidence of MLH1/MSH2 or MUTHY mutations was 1.3% and of MSI-H phenotype was 12%. MLH1 methylation and BRAF mutation can exclude 70% of MSI-H cases from gene sequencing.
引用
收藏
页码:857 / 864
页数:8
相关论文
共 45 条
[1]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]   Two PMS2 mutations in a Turcot syndrome family with small bowel cancers [J].
Agostini, M ;
Tibiletti, MG ;
Lucci-Cordisco, E ;
Chiaravalli, A ;
Morreau, H ;
Furlan, D ;
Boccuto, L ;
Pucciarelli, S ;
Capella, C ;
Boiocchi, M ;
Viel, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08) :1886-1891
[3]   A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors [J].
Agostini, Marco ;
Enzo, Maria Vittoria ;
Morandi, Luca ;
Bedin, Chiara ;
Pizzini, Silvia ;
Mason, Silvia ;
Bertorelle, Roberta ;
Urso, Emanuele ;
Mescoli, Claudia ;
Lise, Mario ;
Pucciarelli, Salvatore ;
Nitti, Donato .
CANCER BIOMARKERS, 2010, 6 (01) :49-61
[4]   Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors [J].
Al-Tassan, N ;
Chmiel, NH ;
Maynard, J ;
Fleming, N ;
Livingston, AL ;
Williams, GT ;
Hodges, AK ;
Davies, DR ;
David, SS ;
Sampson, JR ;
Cheadle, JR .
NATURE GENETICS, 2002, 30 (02) :227-232
[5]   The role of MYH gene in genetic predisposition to colorectal cancer:: Another piece of the puzzle [J].
Avezzu, Alessandra ;
Agostini, Marco ;
Pucciarelli, Salvatore ;
Lise, Mauro ;
Urso, Emanuele Damiano ;
Mammi, Isabella ;
Maretto, Isacco ;
Enzo, Maria Vittoria ;
Pastrello, Chiara ;
Lise, Mario ;
Nitti, Donato ;
Viel, Alessandra .
CANCER LETTERS, 2008, 268 (02) :308-313
[6]   Identification of MYH mutation carriers in colorectal cancer:: A multicenter, case-control, population-based study [J].
Balaguer, Francesc ;
Castellvi-Bel, Sergi ;
Castells, Antoni ;
Andreu, Montserrat ;
Munoz, Jenifer ;
Gisbert, Javier P. ;
Llor, Xavier ;
Jover, Rodrigo ;
De Cid, Rafael ;
Gonzalo, Victoria ;
Bessa, Xavier ;
Xicola, Rosa M. ;
Pons, Elisenda ;
Alenda, Cristina ;
Paya, Artemio ;
Pique, Josep M. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (03) :379-387
[7]   The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside [J].
Boland, C. Richard ;
Koi, Minoru ;
Chang, Dong K. ;
Carethers, John M. .
FAMILIAL CANCER, 2008, 7 (01) :41-52
[8]  
Boland CR, 1998, CANCER RES, V58, P5248
[9]  
Carethers JM, 2006, GUT, V55, P1819
[10]   Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk [J].
Croitoru, ME ;
Cleary, SP ;
Di Nicola, N ;
Manno, M ;
Selander, T ;
Aronson, M ;
Redston, M ;
Cotterchio, M ;
Knight, J ;
Gryfe, R ;
Gallinger, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (21) :1631-1634